

LONDON, Feb 6 (Reuters) - AstraZeneca has been approached a couple of times by Chinese authorities about their investigation into the drugmaker's fo...


(Alliance News) - AstraZeneca PLC on Thursday ended a strong year with better-than-expected fourth quarter earnings and said its pipeline would suppor...


(Alliance News) - Stock prices in London opened higher on Thursday, with the absence of new tariff salvos boosting risk appetite, while the pound fade...


(Sharecast News) - AstraZeneca posted forecast-beating numbers on Thursday, fuelled by strong demand for its cancer and cardiometabolic drugs.


(Alliance News) - London's FTSE 100 is called to open higher on Thursday, with risk appetite returning after a week which has so far been marred by tr...


Indivior PLC - Richmond, Virginia-based maker of medicines to treat substance use disorders - Completes share buyback programme begun in July. Indivio...


(Alliance News) - AstraZeneca PLC on Monday said Imfinzi has been recommended for approval in the EU as monotherapy for limited-stage small cell lung ...


(Alliance News) - European equities are set to tumble at the start of the week, while the dollar powered higher after US President Donald Trump impose...